DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $672,887,393 | +13.2% | 2,712,162 | +9.5% | 3.54% | +23.0% |
| Q2 2023 | $594,584,881 | +58.9% | 2,477,437 | +66.8% | 2.88% | +44.5% |
| Q1 2023 | $374,240,081 | +591.2% | 1,484,844 | +132.8% | 1.99% | +163.6% |
| Q1 2015 | $54,143,000 | -74.8% | 637,723 | -74.6% | 0.76% | -75.5% |
| Q4 2014 | $215,081,000 | -10.0% | 2,509,401 | -20.2% | 3.09% | -17.0% |
| Q3 2014 | $238,948,000 | -2.1% | 3,144,880 | +1.4% | 3.73% | -4.7% |
| Q2 2014 | $244,197,000 | +1.0% | 3,101,700 | -3.8% | 3.91% | -9.8% |
| Q1 2014 | $241,862,000 | -17.7% | 3,224,828 | -15.3% | 4.33% | -19.4% |
| Q4 2013 | $293,920,000 | +10.9% | 3,807,256 | -0.5% | 5.38% | +6.7% |
| Q3 2013 | $265,150,000 | -24.8% | 3,825,008 | -31.3% | 5.04% | -25.9% |
| Q2 2013 | $352,427,000 | – | 5,567,575 | – | 6.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |